Novartis Oncology Controller Salaries in Wilmington, DE | Comparably
At Novartis Oncology, we are passionate about the discovery and development of innovative medicines. read more
EMPLOYEE
PARTICIPANTS
14
TOTAL
RATINGS
161

Novartis Oncology Controller Salaries in Wilmington, DE

The average Novartis Oncology Controller in Wilmington, DE earns an estimated $116,461 annually. Novartis Oncology's Controller compensation is $6,818 less than the US average for a Controller.

In Wilmington, DE, The Finance Department at Novartis Oncology earns $16,348 more on average than the Admin Department.

Last updated 3 years ago.

$47k
$71k
$95k
$118k
$180k
$240k
$300k
$116,461
Average Compensation
$116,461
avg. base

Controller Salaries at Novartis Oncology

In Wilmington, DE, Controllers earn $22,746 more than Business Analysts, and $2,441 less than Accounting Managers.

Accounting Manager
$119k*
Business Analyst
$94k*
Senior Accountant
$90k*
Financial Analyst
$71k*
Accountant
$69k*
* estimated salary

Compensation at Novartis Oncology by Department

In Wilmington, DE, The Finance Department averages $16,348 more than the Admin Department, and $12,531 less than the IT Department

IT
$95,606 Avg. total comp.
+$13k
Finance
$83,075 Avg. total comp.
Admin
$66,727 Avg. total comp.
-$16k

Controller Compensation by Gender (All Companies)

The average female Controller at companies similar size to Novartis Oncology reported making $138,290, while the average male Controller at similar sized companies reported making $133,282.

Controller Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander Controller at companies similar size to Novartis Oncology reported making $132,409, while the average Caucasian Controller at similar sized companies reported making $129,306.

How Controllers at Novartis Oncology Rate Their Compensation

The majority of Controllers at Novartis Oncology believe they're not compensated fairly. 100% of Controllers at Novartis Oncology say they receive annual bonuses, and the vast majority (83%) are satisfied with their benefits. See more compensation ratings at Novartis Oncology

×
Rate your company